On December 14 and 15, our association attended an online council meeting of IFPMA (International Federation of Pharmaceutical Manufacturers and Associations), where IFPMA's 2021 Annual Report was presented.
Strategic priorities and the Equal Access Strategy, Reputation Survey and Communication Strategy for 2022 were also presented.
On December 10th, at the invitation of the Ministry of Health, our association participated in a workshop / seminar held with the support of the World Bank on health policy planning and implementation in the segments of drug pricing and procurement mechanisms.
The speakers at the seminar (international experts) shared their experiences from different countries.
APCRG members general meeting has accepted and validated membership request, submitted by the Representative Office of Novartis Pharma Services AG in Georgia. More information about the company and it's international operations can be seen on company website.
On December 7th a meeting was held at the Ministry of Health, chaired by
Minister of Health, Deputy Minister T. Gabunia and Head of the Drug Agency Z. Kapanadze.
Our association and associations of distributors and local manufacturers were invited from the private sector.
Meeting topic: Going to GMP and GDP standards.
The leadership of the Ministry has introduced some changes in the procedures for the transition to standards.
Most importantly, companies that have certificates of production or wholesale trade in January-May (different years) will have the opportunity to switch to the standards by June 30, 2022 (i.e. the transition deadline has been extended for these companies). As well as manufacturers who will not have GMP certificate, will be able to produce products only for export (not for the Georgian market) until 2025.
On June 16th, the Association of Pharmaceutical Companies Representatives in Georgia, participated in an online seminar organized by IFPMA, where IFPMA members were introduced to the new Regulatory Reliance Toolkit.
At this workshop, Policy Wisdom (IFPMA Partners) presented an overview of this toolkit designed specifically to regulate national-level capabilities. An extensive presentation was presented, which included the following issues:
Toolkit overview;
Introduction to Regulatory reliance
Regulatory reliance: concepts and application
Strategic approach to engagement
Monitoring the path to regulatory reliance
On May 11th, the information portal bm.ge published a comment by Mr. Irakli Margvelashvili regarding the need of pharmaceutical quality control lab. This article can be found at the link.
On May 5th, Irakli Margvelashvili, the Executive Director of APCRG, commented on the prices of medicines in Georgia in a live broadcast on Formula TV, in the tv show "Business with Bloomberg.
Abovementioned interview can be found at the link.
On April 20th, General Meeting of APCRG members have elected members of APCRG Board. Following persons have been elected as Board members:
M. Khetsuriani (Servier), M.Asatiani (Roche), M.Maisuradze (Astra Zeneca), G.Pirtskhalaishvili, K. Ugrekhelidze (Acino Pharma).
On the position of Board Chairman has been elected Mr. Grigori Pirtskhalaishvili.
Association of Pharmaceutical Companies Representatives in Georgia, like in previous years, funded a 3-day free dinner at the House of Charity - "Catharsis" for Easter, during which more than 1,000 people will receive a free dinner.
On April 11th, Executive Director of the Associaiton, Mr. Irakli Margvelashvili made a brief overview of Georgian pharmaceutical market trends within pandemic situation on information portal bm.ge.
The mentioned interview can be found at the link.